Deferasirox Granule
Product Images NDC 69097-550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69097-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 01)

Chemical structure of Deferasirox, showing its molecular framework with multiple hydroxyl groups and ring structures, corresponding to the active ingredient in the prescription drug Deferasirox granules.*

FDA Label Image

Image (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 02)

A bar chart showing the changes in liver iron content and serum ferritin levels at different doses of Deferasirox measured in mg/kg/day. The chart compares liver iron content (white bars) and serum ferritin (black bars) across doses from 5 to 30 mg/kg/day, with sample sizes indicated for each dose group.*

FDA Label Image

90 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 03)

Packaging label for Deferasirox Oral Granules 90 mg by Cipla USA Inc. The carton contains 30 sachets, each sachet containing 162 mg granule equivalent to 90 mg deferasirox. The label includes patient instructions for use, storage conditions, and manufacturer information including Cipla Ltd, Kurkumbh, India, and Cipla USA Inc. It also notes the package is child-resistant and includes a barcode.*

FDA Label Image

180 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 04)

Deferasirox Oral Granules 180 mg carton packaging label. The label shows dosing instructions, pharmacist dispensing advice, and storage conditions. The product is distributed by Cipla USA Inc. and manufactured by Cipla Ltd. in India. The package contains 30 sachets, each with granules equivalent to 180 mg deferasirox. The label includes barcode and NDC 69097-560-53.*

FDA Label Image

360 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 05)

Deferasirox Oral Granules 360 mg carton label by Cipla USA Inc. The label features dosage form as oral granules in sachets with 30 sachets per carton. Dosage strength is prominently displayed in purple boxes. Instructions for patient use, storage conditions, and pharmacist dispensing information are included. Manufactured by Cipla Ltd., Kurkumbh, India, and distributed by Cipla USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.